Johnson & Johnson Says Q3 Reflects One-Time Special Charge for Proposed Talc Litigation Resolution, Acquisition of Firefly Bio, And Strategic Collaboration With Sail Biomedicines
Johnson & Johnson Says Q3 Reflects One-Time Special Charge for Proposed Talc Litigation Resolution, Acquisition of Firefly Bio, And Strategic Collaboration With Sail Biomedicines
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed